KOD News and Press, Kodiak Sciences Inc From 11/18/19

Buying stocks just because they're going up is a great way to lose a lot of money, but that doesn't mean you should avoid every company that's signaling signs of success. These three small-cap biotech stocks have been rocketing higher all year and for good reasons. They're all heading toward th...

Kodiak Sciences, Inc. (KOD) Q3 2019 Results Conference Call November 12, 2019 05:00 PM ET Company Participants John Borgeson - Chief Financial Officer Victor Perlroth - Chief Executive Officer Jason Ehrlich - Chief Medical Officer and Chief Development Officer Conference Call ...

Image source: The Motley Fool. Kodiak Sciences Inc.   (NASDAQ: KOD) Q3 2019 Earnings Call Nov 13, 2019 , 8:00 p.m. ET Operator Continue reading

Kodiak Sciences (NASDAQ: KOD ): Q3 GAAP EPS of -$0.33 in-line. More news on: Kodiak Sciences Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

PALO ALTO, Calif. , Nov. 12, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today reported business highlights and financial results for the thi...

PALO ALTO, Calif. , Nov. 8, 2019 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases, today announced that it will report third quarter 2019 results on Tu...

Biotech Pulse Biotech finally has a pulse. The improving appetite for risk has resuscitated the moribund biotechs and pharma (biopharma) groups. The Nasdaq Biotech ( IBB ) and the S&P Biotech ( XBI ) indexes have begun their advance from their year-to-date lows recorded earlier in Octo...

Despite starting the year off strong, biotech stocks have had a rough summer. The recent weakness in the biotech sector is causing biotech exchange-traded funds (ETFs) like the VanEck Vectors Biotech ETF (BBH), the iShares NASDAQ Biotechnology ETF (IBB), and the SPDR S&P Bio...

Looking for stocks with big potential that have been overlooked? There's probably something in the biotech industry right up your alley. There are so many new biotech stocks hitting the market that plenty of gems slip through the cracks unnoticed. Since the beginning of 2018, around 100 new b...

This is a special contribution article by Prof. Grant Henning based on his published research on the BLM technical theory . The model, his trailing stop-loss approach, and comments are expressly based on his own proprietary methodology and forecasts in the references below. Winning Bounc...